Advanced search
Publication Cover
OncoImmunology Volume 5, 2016 - Issue 8
Submit an article Journal homepage
1,074
Views
29
CrossRef citations to date
0
Altmetric
Original Research

Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments

Elisabetta CarianiClinical Pathology-Toxicology, Ospedale Civile, Modena, Italy
,
Massimo PilliInfectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
,
Valeria BariliInfectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
,
Emanuela PorroInfectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
,
Elisabetta BiasiniInfectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
,
Andrea OlivaniInfectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
,
Raffaele Dalla ValleDepartment of Surgery, University of Parma, Parma, Italy
,
Tommaso TrentiClinical Pathology-Toxicology, Ospedale Civile, Modena, Italy
,
Carlo FerrariInfectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
&
Gabriele MissaleInfectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, ItalyCorrespondence[email protected]
 show all
Article: e1154249 | Received 07 Oct 2015, Accepted 09 Feb 2016, Published online: 29 Jul 2016

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Blaise Kutala, Dominique Valla & Patrick Marcellin. (2018) Things fall apart with hepatocellular carcinoma and direct-acting antivirals. Expert Opinion on Drug Safety 17:2, pages 107-109.
Read now

Articles from other publishers (28)

Alessandra Zecca, Valeria Barili, Carolina Boni, Paola Fisicaro, Andrea Vecchi, Marzia Rossi, Valentina Reverberi, Anna Montali, Giuseppe Pedrazzi, Carlo Ferrari, Elisabetta Cariani & Gabriele Missale. (2023) High CD49a+ NK cell infiltrate is associated with poor clinical outcomes in Hepatocellular Carcinoma. Heliyon 9:12, pages e22680.
Crossref
Kai Zhang & Enwu Yuan. (2023) Combined analysis of bulk and single-cell RNA sequencing reveals novel natural killer cell-related prognostic biomarkers for predicting immunotherapeutic response in hepatocellular carcinoma. Frontiers in Immunology 14.
Crossref
Chen Chen, Zehua Wang, Yi Ding & Yanru Qin. (2023) Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma. Frontiers in Immunology 14.
Crossref
Chaoran Zang, Yan Zhao, Guihai Liu, Kang Li, Ling Qin, Yuewei Zhang, Jianping Sun, Qi Wang, Liang Ma, Peng Zhao, Yu Sun, Dandan Guo, Chunwang Yuan, Tao Dong & Yonghong Zhang. (2022) Variations in dynamic tumor-associated antigen-specific T cell responses correlate with HCC recurrence after thermal ablation. Frontiers in Immunology 13.
Crossref
Friedrich Foerster, Simon Johannes Gairing, Sumera Irie Ilyas & Peter Robert Galle. (2022) Emerging immunotherapy for HCC: A guide for hepatologists. Hepatology 75:6, pages 1604-1626.
Crossref
Alessandra Zecca, Valeria Barili, Andrea Olivani, Elisabetta Biasini, Carolina Boni, Paola Fisicaro, Ilaria Montali, Camilla Tiezzi, Raffaele Dalla Valle, Carlo Ferrari, Elisabetta Cariani & Gabriele Missale. (2022) Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer. Frontiers in Immunology 13.
Crossref
Muhammad Sajid, Lianxin Liu & Cheng Sun. (2022) The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications. Frontiers in Immunology 13.
Crossref
Markus Bo Schoenberg, Tong Zhu, Jingcheng Hao, Julian Nikolaus Bucher, Xiaokang Li, Xinyu Li, Yongsheng Han, Dionysios Koliogiannis, Michaela Svihla, Markus Otto Guba, Jens Werner & Alexandr V. Bazhin. (2021) Highly differential count of circulating and tumor infiltrating immune cells in patients with non-HCV/non-HBV hepatocellular carcinoma. Cancer Immunology, Immunotherapy 71:5, pages 1103-1113.
Crossref
David Repáraz, Belén Aparicio, Diana Llopiz, Sandra Hervás-Stubbs & Pablo Sarobe. (2022) Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?. International Journal of Molecular Sciences 23:4, pages 2022.
Crossref
Bruno Sangro, Pablo Sarobe, Sandra Hervás-Stubbs & Ignacio Melero. (2021) Advances in immunotherapy for hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology 18:8, pages 525-543.
Crossref
Charlotte Rennert, Catrin Tauber, Pia Fehrenbach, Kathrin Heim, Dominik Bettinger, Özlem Sogukpinar, Anita Schuch, Britta Franziska Zecher, Bertram Bengsch, Sven A. Lang, Peter Bronsert, Niklas K. Björkström, Stefan Fichtner-Feigl, Michael Schultheiss, Robert Thimme & Maike Hofmann. (2021) Adaptive Subsets Limit the Anti-Tumoral NK-Cell Activity in Hepatocellular Carcinoma. Cells 10:6, pages 1369.
Crossref
Amber G. Bozward, Frazer Warricker, Ye H. Oo & Salim I. Khakoo. (2021) Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade. Frontiers in Immunology 12.
Crossref
Alessandra Zecca, Valeria Barili, Danila Rizzo, Andrea Olivani, Elisabetta Biasini, Diletta Laccabue, Raffaele Dalla Valle, Carlo Ferrari, Elisabetta Cariani & Gabriele Missale. (2021) Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma. Cells 10:3, pages 614.
Crossref
Yue Li, Xiaoqin He, Xiaoyu Zhang, Yangtao Xu, Yaogui Wu & Ximing Xu. (2021) Immune-related microRNA signature for predicting prognosis and the immune microenvironment in hepatocellular carcinoma. Life Sciences 265, pages 118799.
Crossref
Jie Hu, Enxin Wang, Lei Liu, Qiuhe Wang, Dongdong Xia, Wei Bai, Jun Tie, Xiaomei Li, Jie Yuan, Shuya Yang, Dongbo Jiang, Jingqi Shi, Yuanjie Sun, Jing Wang, Chunmei Zhang, Jing Niu, Kai Li, Chuangye He, Wengang Guo, Yong Lv, Hui Chen, Xulong Yuan, Tianlei Yu, Zhengyu Wang, Bohan Luo, Na Han, Ying Zhu, Zhanxin Yin, Daiming Fan, Zhuoli Zhang, Kun Yang & Guohong Han. (2019) Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cells. Investigational New Drugs 38:5, pages 1247-1256.
Crossref
Alessandra Zecca, Valeria Barili, Diana Canetti, Valeria Regina, Andrea Olivani, Chiara Carone, Valentina Capizzuto, Barbara Zerbato, Tommaso Trenti, Raffaele Dalla Valle, Carlo Ferrari, Elisabetta Cariani & Gabriele Missale. (2020) Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma. Cancer Immunology, Immunotherapy 69:8, pages 1589-1603.
Crossref
C Wendy Spearman, Geoffrey M Dusheiko, Margaret Hellard & Mark Sonderup. (2019) Hepatitis C. The Lancet 394:10207, pages 1451-1466.
Crossref
Elisabetta Cariani & Gabriele Missale. (2019) Immune landscape of hepatocellular carcinoma microenvironment: Implications for prognosis and therapeutic applications. Liver International 39:9, pages 1608-1621.
Crossref
Chen Han, Yongjie Jiang, Zhaoxia Wang & Hengxiao Wang. (2019) Natural killer cells involved in tumour immune escape of hepatocellular carcinomar. International Immunopharmacology 73, pages 10-16.
Crossref
Stefania Mantovani, Barbara Oliviero, Andrea Lombardi, Stefania Varchetta, Dalila Mele, Angelo Sangiovanni, Giorgio Rossi, Matteo Donadon, Guido Torzilli, Cristiana Soldani, Camillo Porta, Paolo Pedrazzoli, Silvia Chiellino, Roberto Santambrogio, Enrico Opocher, Marcello Maestri, Stefano Bernuzzi, Armando Rossello, Sophie Clément, Claudio De Vito, Laura Rubbia‐Brandt, Francesco Negro & Mario U. Mondelli. (2019) Deficient Natural Killer Cell NKp30‐Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma. Hepatology 69:3, pages 1165-1179.
Crossref
Giulia Mazzaschi, Francesco Facchinetti, Gabriele Missale, Diana Canetti, Denise Madeddu, Alessandra Zecca, Michele Veneziani, Francesco Gelsomino, Matteo Goldoni, Sebastiano Buti, Paola Bordi, Franco Aversa, Andrea Ardizzoni, Federico Quaini & Marcello Tiseo. (2019) The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC. Lung Cancer 127, pages 153-163.
Crossref
Kelly A. Borges, Jianliang Dai, Neehar D. Parikh, Myron Schwartz, Mindie H. Nguyen, Lewis R. Roberts, Alex S. Befeler, Sudhir Srivastava, Jo Ann Rinaudo, Ziding Feng, Jorge A. Marrero & K. Rajender Reddy. (2019) Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute’s Early Detection Research Network. Contemporary Clinical Trials 76, pages 49-54.
Crossref
Samantha Burugu, Amanda R. Dancsok & Torsten O. Nielsen. (2018) Emerging targets in cancer immunotherapy. Seminars in Cancer Biology 52, pages 39-52.
Crossref
Antonietta Romano, Paolo Angeli, Sara Piovesan, Franco Noventa, Georgios Anastassopoulos, Liliana Chemello, Luisa Cavalletto, Martina Gambato, Francesco Paolo Russo, Patrizia Burra, Valter Vincenzi, Pier Giorgio Scotton, Sandro Panese, Diego Tempesta, Tosca Bertin, Maurizio Carrara, Antonio Carlotto, Franco Capra, Giada Carolo, Giovanna Scroccaro & Alfredo Alberti. (2018) Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study. Journal of Hepatology 69:2, pages 345-352.
Crossref
N. Kumar & S. I. Khakoo. (2018) Hepatocellular carcinoma: Prospects for natural killer cell immunotherapy. HLA 92:1, pages 3-11.
Crossref
Ivan Schietroma, Giuseppe Corano Scheri, Claudia Pinacchio, Maura Statzu, Arnolfo Petruzziello & Vincenzo Vullo. (2018) Hepatitis C Virus and Hepatocellular Carcinoma: Pathogenetic Mechanisms and Impact of Direct-Acting Antivirals. The Open Virology Journal 12:1, pages 16-25.
Crossref
Kate Childs, Elliot Merritt, Aisling Considine, Alberto Sanchez-Fueyo, Kosh Agarwal, Marc Martinez-Llordella & Ivana Carey. (2017) Immunological Predictors of Nonresponse to Directly Acting Antiviral Therapy in Patients With Chronic Hepatitis C and Decompensated Cirrhosis. Open Forum Infectious Diseases 4:2.
Crossref
Elisabetta Cariani & Gabriele Missale. 2017. Immunotherapy of Hepatocellular Carcinoma. Immunotherapy of Hepatocellular Carcinoma 19 38 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.